Streetbeat News

Stock Prices

AVB

Over the past 3 months, 9 analysts have published their opinion on AvalonBay Communities (NYSE:AVB) stock. The average 12-month price target for AVB is $194.22, with a high of $205.00 and a low of $179.00. This average price target has increased by 1.42% over the past month.

Portfolio Pulse from Benzinga Insights

October 03, 2023 | 12:01 pm

ABNB

Airbnb (NASDAQ:ABNB) has received various analyst ratings in the last quarter, with 7 bullish, 2 somewhat bullish, 8 indifferent, 3 somewhat bearish, and 1 bearish. The average 12-month price target for Airbnb, according to 21 analysts, is $144.0, an increase of 14.52% from the previous average price target of $125.74.

Portfolio Pulse from Benzinga Insights

October 03, 2023 | 12:00 pm

FMC

Over the past 3 months, 20 analysts have published their opinion on FMC (NYSE:FMC) stock. The average price target is $111.6, implying an upside from the current price of $65.25. This average has decreased by 16.9% from the previous average price target of $134.29.

Portfolio Pulse from Benzinga Insights

October 03, 2023 | 12:00 pm

WLK

Westlake (NYSE:WLK) has received 13 analyst ratings in the last quarter, with 2 somewhat bullish, 8 indifferent, and 3 somewhat bearish. The average price target is $130.0, indicating an upside from the current price of $122.86. This average has increased by 6.69% from the previous average price target of $121.85.

Portfolio Pulse from Benzinga Insights

October 03, 2023 | 12:00 pm

WE

WeWork Inc. (NYSE:WE) has chosen not to make aggregate interest payments totaling about $95.2 million, due in 2023, despite having the liquidity to do so. The company has a 30-day grace period before this is considered a default. WeWork is using this time to converse with key stakeholders and save cash while working on its strategic plan. The company's shares are trading lower by 7.12% at $2.74 in premarket trading on Tuesday.

Portfolio Pulse from Akanksha Bakshi

October 03, 2023 | 11:56 am

LLY

PNT

Eli Lilly has agreed to acquire Point Biopharma at $12.50/share in cash, causing Point Biopharma's shares to trade higher.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2023 | 11:54 am

PPBT

Purple Biotech Ltd. (NASDAQ/TASE: PPBT) has reported positive interim and preliminary results from its Phase 1/2 study of NT219, a first-in-class dual inhibitor of IRS 1/2 and STAT3. The company is planning the next clinical development steps with NT219 for second-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head & neck.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2023 | 11:51 am

VERY

Trading of Vericity's shares is set to resume at 8:00 AM ET.

Portfolio Pulse from Charles Gross

October 03, 2023 | 11:44 am

DNUT

Krispy Kreme, Inc. (NASDAQ:DNUT) is considering strategic alternatives for Insomnia Cookies, including a potential all-cash sale. The company acquired a majority stake in Insomnia Cookies in 2018 and expects revenues of approximately $230 million in fiscal year 2023. This decision is aimed at unlocking shareholder value and focusing on Krispy Kreme's core strategy.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2023 | 11:33 am

VERY

Shares of Vericity were halted ahead of an announcement regarding its acquisition.

Portfolio Pulse from Charles Gross

October 03, 2023 | 11:32 am